178 related articles for article (PubMed ID: 34051236)
1. Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner.
Singh RR; McNamara JW; Sadayappan S
J Biol Chem; 2021 Jul; 297(1):100836. PubMed ID: 34051236
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
Da'as SI; Fakhro K; Thanassoulas A; Krishnamoorthy N; Saleh A; Calver BL; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
Biochem J; 2018 Dec; 475(24):3933-3948. PubMed ID: 30446606
[TBL] [Abstract][Full Text] [Related]
3. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C.
Gruen M; Gautel M
J Mol Biol; 1999 Feb; 286(3):933-49. PubMed ID: 10024460
[TBL] [Abstract][Full Text] [Related]
4. Cardiac myosin-binding protein C N-terminal interactions with myosin and actin filaments: Opposite effects of phosphorylation and M-domain mutations.
Wong FL; Bunch TA; Lepak VC; Steedman AL; Colson BA
J Mol Cell Cardiol; 2024 Jan; 186():125-137. PubMed ID: 38008210
[TBL] [Abstract][Full Text] [Related]
5. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Contribution of a Thermodynamic and Mechanical Destabilization of Myosin-Binding Protein C Domain C2 to the Pathomechanism of Hypertrophic Cardiomyopathy-Causing Double Mutation
Schwäbe FV; Peter EK; Taft MH; Manstein DJ
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769381
[TBL] [Abstract][Full Text] [Related]
7. The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production.
Bell KM; Kronert WA; Huang A; Bernstein SI; Swank DM
J Physiol; 2019 May; 597(9):2403-2420. PubMed ID: 30950055
[TBL] [Abstract][Full Text] [Related]
8. MYBPC3-c.772G>A mutation results in haploinsufficiency and altered myosin cycling kinetics in a patient induced stem cell derived cardiomyocyte model of hypertrophic cardiomyopathy.
Steczina S; Mohran S; Bailey LRJ; McMillen TS; Kooiker KB; Wood NB; Davis J; Previs MJ; Olivotto I; Pioner JM; Geeves MA; Poggesi C; Regnier M
J Mol Cell Cardiol; 2024 Jun; 191():27-39. PubMed ID: 38648963
[TBL] [Abstract][Full Text] [Related]
9. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
[TBL] [Abstract][Full Text] [Related]
10. The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
Nag S; Trivedi DV; Sarkar SS; Adhikari AS; Sunitha MS; Sutton S; Ruppel KM; Spudich JA
Nat Struct Mol Biol; 2017 Jun; 24(6):525-533. PubMed ID: 28481356
[TBL] [Abstract][Full Text] [Related]
11.
Desai D; Song T; Singh RR; Baby A; McNamara J; Green L; Nabavizadeh P; Ericksen M; Bazrafshan S; Natesan S; Sadayappan S
bioRxiv; 2024 May; ():. PubMed ID: 38853909
[TBL] [Abstract][Full Text] [Related]
12. Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2.
Kunst G; Kress KR; Gruen M; Uttenweiler D; Gautel M; Fink RH
Circ Res; 2000 Jan 7-21; 86(1):51-8. PubMed ID: 10625305
[TBL] [Abstract][Full Text] [Related]
13. Human cardiac myosin-binding protein C restricts actin structural dynamics in a cooperative and phosphorylation-sensitive manner.
Bunch TA; Kanassatega RS; Lepak VC; Colson BA
J Biol Chem; 2019 Nov; 294(44):16228-16240. PubMed ID: 31519753
[TBL] [Abstract][Full Text] [Related]
14. Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.
Vera CD; Johnson CA; Walklate J; Adhikari A; Svicevic M; Mijailovich SM; Combs AC; Langer SJ; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
J Biol Chem; 2019 Nov; 294(46):17451-17462. PubMed ID: 31582565
[TBL] [Abstract][Full Text] [Related]
15. N-terminal extension in cardiac myosin-binding protein C regulates myofilament binding.
Bunch TA; Lepak VC; Kanassatega RS; Colson BA
J Mol Cell Cardiol; 2018 Dec; 125():140-148. PubMed ID: 30359561
[TBL] [Abstract][Full Text] [Related]
16. Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin.
McNamara JW; Singh RR; Sadayappan S
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11731-11736. PubMed ID: 31142654
[TBL] [Abstract][Full Text] [Related]
17. Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy.
Kraft T; Montag J
Pflugers Arch; 2019 May; 471(5):719-733. PubMed ID: 30740621
[TBL] [Abstract][Full Text] [Related]
18. Structure and interactions of myosin-binding protein C domain C0: cardiac-specific regulation of myosin at its neck?
Ratti J; Rostkova E; Gautel M; Pfuhl M
J Biol Chem; 2011 Apr; 286(14):12650-8. PubMed ID: 21297165
[TBL] [Abstract][Full Text] [Related]
19. Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.
Jacques AM; Copeland O; Messer AE; Gallon CE; King K; McKenna WJ; Tsang VT; Marston SB
J Mol Cell Cardiol; 2008 Aug; 45(2):209-16. PubMed ID: 18573260
[TBL] [Abstract][Full Text] [Related]
20. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
